Impact of COVID-19 pandemic on mental health in the general population: A systematic review J Xiong, O Lipsitz, F Nasri, LMW Lui, H Gill, L Phan, D Chen-Li, ... Journal of affective disorders 277, 55-64, 2020 | 5422 | 2020 |
Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis F Ceban, S Ling, LMW Lui, Y Lee, H Gill, KM Teopiz, NB Rodrigues, ... Brain, behavior, and immunity 101, 93-135, 2022 | 984 | 2022 |
Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation RS McIntyre, JD Rosenblat, CB Nemeroff, G Sanacora, JW Murrough, ... American Journal of Psychiatry 178 (5), 383-399, 2021 | 397 | 2021 |
Onset and frequency of depression in post-COVID-19 syndrome: A systematic review O Renaud-Charest, LMW Lui, S Eskander, F Ceban, R Ho, ... Journal of psychiatric research 144, 129-137, 2021 | 292 | 2021 |
Recognition and treatment of cognitive dysfunction in major depressive disorder H Zuckerman, Z Pan, C Park, E Brietzke, N Musial, AS Shariq, ... Frontiers in psychiatry 9, 402691, 2018 | 234 | 2018 |
Government response moderates the mental health impact of COVID-19: a systematic review and meta-analysis of depression outcomes across countries Y Lee, LMW Lui, D Chen-Li, Y Liao, RB Mansur, E Brietzke, JD Rosenblat, ... Journal of affective disorders 290, 364-377, 2021 | 205 | 2021 |
Association between mood disorders and risk of COVID-19 infection, hospitalization, and death: a systematic review and meta-analysis F Ceban, D Nogo, IP Carvalho, Y Lee, F Nasri, J Xiong, LMW Lui, ... JAMA psychiatry 78 (10), 1079-1091, 2021 | 185 | 2021 |
The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis RS McIntyre, IP Carvalho, LMW Lui, A Majeed, PS Masand, H Gill, ... Journal of affective disorders 276, 576-584, 2020 | 150 | 2020 |
Impact of SARS-CoV-2 infection on cognitive function: a systematic review Y Alnefeesi, A Siegel, LMW Lui, KM Teopiz, RCM Ho, Y Lee, F Nasri, ... Frontiers in Psychiatry 11, 621773, 2021 | 108 | 2021 |
The mental health effects of COVID-19 on health care providers in China K Lin, BX Yang, D Luo, Q Liu, S Ma, R Huang, W Lu, A Majeed, Y Lee, ... American Journal of Psychiatry 177 (7), 635-636, 2020 | 100 | 2020 |
Ecological momentary assessment of depressive symptoms using the mind. me application: Convergence with the Patient Health Questionnaire-9 (PHQ-9) RS McIntyre, Y Lee, C Rong, JD Rosenblat, E Brietzke, Z Pan, C Park, ... Journal of Psychiatric Research 135, 311-317, 2021 | 95 | 2021 |
Antidepressant medications and weight change: a narrative review H Gill, B Gill, S El‐Halabi, D Chen‐Li, O Lipsitz, JD Rosenblat, ... Obesity 28 (11), 2064-2072, 2020 | 93 | 2020 |
Predictors of response to ketamine in treatment resistant major depressive disorder and bipolar disorder C Rong, C Park, JD Rosenblat, M Subramaniapillai, H Zuckerman, D Fus, ... International Journal of Environmental Research and Public Health 15 (4), 771, 2018 | 93 | 2018 |
The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: a systematic review and … J Xiong, O Lipsitz, D Chen-Li, JD Rosenblat, NB Rodrigues, I Carvalho, ... Journal of psychiatric research 134, 57-68, 2021 | 89 | 2021 |
The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar … RS McIntyre, NB Rodrigues, Y Lee, O Lipsitz, M Subramaniapillai, H Gill, ... Journal of Affective Disorders 274, 903-910, 2020 | 77 | 2020 |
Molecular mechanisms of psilocybin and implications for the treatment of depression S Ling, F Ceban, LMW Lui, Y Lee, KM Teopiz, NB Rodrigues, O Lipsitz, ... CNS drugs 36 (1), 17-30, 2022 | 68 | 2022 |
Registered clinical studies investigating psychedelic drugs for psychiatric disorders AN Siegel, S Meshkat, K Benitah, O Lipsitz, H Gill, LMW Lui, KM Teopiz, ... Journal of Psychiatric Research 139, 71-81, 2021 | 61 | 2021 |
Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research F Ceban, A Leber, MY Jawad, M Yu, LMW Lui, M Subramaniapillai, ... Infectious Diseases 54 (7), 467-477, 2022 | 57 | 2022 |
Suicide reduction in Canada during the COVID-19 pandemic: lessons informing national prevention strategies for suicide reduction RS McIntyre, LMW Lui, JD Rosenblat, R Ho, H Gill, RB Mansur, K Teopiz, ... Journal of the Royal Society of Medicine 114 (10), 473-479, 2021 | 57 | 2021 |
A systematic review of the validity of screening depression through Facebook, Twitter, Instagram, and Snapchat J Kim, ZA Uddin, Y Lee, F Nasri, H Gill, M Subramanieapillai, R Lee, ... Journal of affective disorders 286, 360-369, 2021 | 54 | 2021 |